Introduction
The Asian Institute of Medical Sciences has successfully facilitated the exit of its private equity investors, OrbiMed Asia II Mauritius Limited and British International Investment (BII). This strategic maneuver was achieved through a private credit facility from 360 ONE and the refinancing of an existing loan from HDFC Bank by Hero FinCorp.
DSK Legal’s Role
The transaction was expertly managed by DSK Legal, a renowned law firm, which provided comprehensive legal counsel to the Asian Institute of Medical Sciences and its promoters, Dr. N. K. Pandey and his family. The firm’s advisory role encompassed the acquisition of shares held by OrbiMed and BII in Asian Hospitals. Additionally, DSK Legal was instrumental in structuring the financing transactions with 360 ONE and Hero FinCorp, drafting, negotiating, and finalizing all necessary transaction documents, and ensuring compliance with regulatory requirements.
Leading the Transaction
The diligent efforts of the DSK Legal team were spearheaded by Nakul Batra, Partner, who was supported by a proficient team including Palak Sehgal (Associate Partner), Devbrat Singh (Principal Associate), Rishi Shah (Senior Associate), Aankhi Anwesha (Senior Associate), and Associates Utkarsh Sharma, Daksh Krishnan, and Utkarsh Vaishnav. Their collaborative efforts ensured the seamless execution of the transaction.
Litigation and Risk Mitigation
For aspects related to litigation and risk mitigation, the firm’s team was led by Dinesh Pardasani, Partner, with the assistance of Bibin Kurian (Principal Associate), and Associates Parth Tiwari and Srishty Bajaj. Their strategic insights were pivotal in managing potential legal risks and ensuring the transaction’s success.
Conclusion
This transaction highlights DSK Legal’s expertise in managing complex financial deals and providing tailored solutions to meet client needs. It underscores the firm’s capability in handling multi-faceted legal challenges and delivering outcomes that align with client objectives.
